A Potential Case of Acute Ketamine Withdrawal: Clinical Implications for the Treatment of Refractory Depression

被引：7
|
作者：
Roxas, Nichole [1 ]
Ahuja, Chaarushi [1 ]
Isom, Jessica [1 ]
Wilkinson, Samuel T. [1 ]
Capurso, Noah [1 ]
机构：
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2021年 / 178卷 / 07期
关键词：
STAR-ASTERISK-D; ANTIDEPRESSANT;
D O I：
10.1176/appi.ajp.2020.20101480
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页码：588 / 591
页数：4
相关论文
共 50 条
  • [31] Ketamine cystitis following ketamine therapy for treatment-resistant depression - case report
    Chang, Minna
    Juruena, Mario F.
    Young, Allan H.
    BMC PSYCHIATRY, 2024, 24 (01)
  • [32] Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
    Minna Chang
    Mario F Juruena
    Allan H Young
    BMC Psychiatry, 24
  • [33] Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression
    Spangemacher, M.
    Reinwald, J.
    Boettcher, M.
    Gilles, M.
    Walter, M.
    Sartorius, A.
    Gruender, G.
    PHARMACOPSYCHIATRY, 2022, 55 (03) : 170 - 170
  • [34] Accelerated rTMS: A Potential Treatment to Alleviate Refractory Depression
    Baeken, Chris
    FRONTIERS IN PSYCHOLOGY, 2018, 9
  • [35] Use Of Intravenous Ketamine In The Treatment Of Resistant Depression: A Case Report
    Patel, Dhawal
    Kataria, Lakhan
    Goyal, Parth
    INDIAN JOURNAL OF PSYCHIATRY, 2017, 59 (06) : S228 - S228
  • [36] Subcutaneous ketamine in the treatment of depression and suicide risk: case report
    Cigognini, M. A.
    Meene, D. V. D.
    EUROPEAN PSYCHIATRY, 2023, 66 : S1010 - S1011
  • [37] Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression
    Parikh, Sagar V.
    Vande Voort, Jennifer L.
    Yocum, Anastasia K.
    Achtyes, Eric
    Goes, Fernando S.
    Nykamp, Louis
    Singh, Balwinder
    Lopez-Vives, Daniela
    Sera, Cortney E.
    Maixner, Daniel
    Tarnal, Vijay
    Severe, Jennifer
    Bartek, Steven
    Tye, Susannah J.
    Rico, Jose
    Stoppel, Cynthia J.
    Becerra, Alexis
    Smart, LeAnn
    Miller, Christina R.
    Frye, Mark A.
    Greden, John F.
    Bobo, William V.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 348 : 143 - 151
  • [38] Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish
    Opler, Lewis A.
    Opler, Mark G. A.
    Arnsten, Amy F. T.
    CNS SPECTRUMS, 2016, 21 (01) : 12 - 22
  • [39] Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
    Lauritsen, Clinton
    Mazuera, Santiago
    Lipton, Richard B.
    Ashina, Sait
    JOURNAL OF HEADACHE AND PAIN, 2016, 17
  • [40] Intravenous Ketamine for the Subacute Treatment of Refractory Chronic Migraine: Case Series
    Mazuera, S.
    Ashina, S.
    Lipton, R. B.
    HEADACHE, 2015, 55 : 144 - 144
12345